Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) FCF Margin (2016 - 2026)

Standard Biotools has reported FCF Margin over the past 16 years, most recently at 39.33% for Q4 2025.

  • Quarterly FCF Margin rose 466.0% to 39.33% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 78.04% through Dec 2025, up 4840.0% year-over-year, with the annual reading at 96.85% for FY2025, 6277.0% up from the prior year.
  • FCF Margin was 39.33% for Q4 2025 at Standard Biotools, up from 78.74% in the prior quarter.
  • Over five years, FCF Margin peaked at 36.75% in Q2 2023 and troughed at 174.92% in Q3 2021.
  • The 5-year median for FCF Margin is 78.74% (2025), against an average of 91.3%.
  • Year-over-year, FCF Margin tumbled -16253bps in 2021 and then soared 12795bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 174.92% in 2021, then surged by 58bps to 73.78% in 2022, then surged by 46bps to 40.12% in 2023, then decreased by -10bps to 43.99% in 2024, then increased by 11bps to 39.33% in 2025.
  • Per Business Quant, the three most recent readings for LAB's FCF Margin are 39.33% (Q4 2025), 78.74% (Q3 2025), and 103.64% (Q2 2025).